PTK2 and head and neck squamous cell carcinoma: To determine whether FAK inhibition alone is sufficient to inhibit HNSCC cell viability, and thereby support its importance as a critical node in HNSCC, four HNSCC cell lines were treated with two independent FAK inhibitors for 72 h and cell viability was assessed using CyQUANT.